Introduction. The pandemic of the coronavirus disease conditions the search for more significant clinical and laboratory manifestations of the disease and its complications, which can be achieved through the widespread introduction into clinical practice of modern methods of laboratory diagnostics. Aim: to determine the feasibility of using flow cytometry based on the analysis of changes in the general blood analysis of patients with COVID-19. Materials and methods. The results of leukocyte count indicators in the general blood analysis of 20 aged medical workers (55.3±2.4 years old) with COVID-19, who, according to the results of previous medical examinations, did not have chronic blood diseases, were considered. In the study, only the data of the general blood test during hospitalization before the start of treatment were taken into account. Research results and their discussion. When analyzing changes in the general blood test in patients with a similar clinical course of COVID-19, the authors demonstrated typical changes in individual indicators of the leukocyte count and the leukocyte formula in general. In 20 patients with COVID-19-associated pneumonia confirmed clinically by chest computed tomography and real-time polymerase chain reaction, visible changes in the white blood cell count were mostly absent or of a nature that did not allow to correlate them with typical leukocyte reaction in viral infection. The data of the complete blood count did not have reliable correlations with the clinic, other laboratory indicators and the results of treatment. Conclusions. In 25% of cases of patients with COVID-19, there are no changes in the leukocyte formula specific to a viral infection, and in another 50% of cases, changes in the content of leukocytes are of an undefined nature. The weak correlation between the indicators of the blood leukocyte series and the patient’s clinical condition indicates a limited possibility of reliable interpretation of the results of general clinical examination methods. The introduction of flow cytometry to control blood changes in patients with coronavirus infection is the most promising and expedient step for solving the existing problems of laboratory diagnostics.